Brief: AVITA Medical Submits FDA PMA Supplement For RECELL GO
29/06/2023 23:27
June 29 (Reuters) - AVITA Medical Inc RCEL.O :
* AVITA MEDICAL SUBMITS FDA PMA SUPPLEMENT FOR RECELL GO
* AVITA MEDICAL- UNDER FDA BREAKTHROUGH DEVICE PROGRAM,
SUBMISSION
WILL RECEIVE PRIORITIZED, INTERACTIVE REVIEW WITH EXPECTED
JANUARY 2024 APPROVAL
Source text for Eikon: ID:nGNXccZfk2
Further company coverage: RCEL.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on AVITA Medical
See all newsAvita Medical Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview
Brief: AVITA Medical Q1 EPS USD -0.35
Brief: AVITA Medical Q4 EPS USD -0.38
Brief: Avita Medical Inc - Enters Into Credit Agreement And Guaranty - SEC Filing